Enhancing N-Nitrosamine Risk Assessment with Read-across: A Valuable Addition to Standard CPCA Calculators Candice Johnson, PhDFebruary 27, 2025In Silico Insider: Candice Johnson, PhD
Leveraging a 20,000 Chemical Database to Advance Acute Rat Oral Toxicity Predictions Candice Johnson, PhDFebruary 21, 2025In Silico Insider: Candice Johnson, PhD
Advancing Safety Standards: International Guidelines and In Silico ToxicologyCandice Johnson, PhDJanuary 15, 2025In Silico Insider: Candice Johnson, PhD
Streamlining Toxicity Predictions with In Silico ProfilingCandice Johnson, PhDDecember 12, 2024Read the latest from the In Silico Insider blog!
Instem Enables Clients to Leverage ICH S1B Weight of Evidence GuidelineInstem TeamJanuary 25, 2024Advance™ technology-enabled solution enables R&D organizations to cut study timelines, deliver cost savings and reduce animal experimentation.
Instem Now Part of ARCHIMED to Further Accelerate Growth and ImpactInstem TeamNovember 27, 2023Healthcare investment specialist ARCHIMED has the expertise, experience, enthusiasm and financial strength to fully back Instem’s ambitions.